v3.26.1
Stockholders' Equity - Summary of Common Stock Shares Activity (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 25, 2026
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Common Stock Outstanding Roll Forward [Roll Forward]          
Beginning balance   $ 41,307 $ 50,532 $ 49,376 $ 55,077
Beginning balance (in shares)       5,442,688  
Net income (loss)   7,397 (6,885) $ (13,902) (12,276)
Stock-based compensation expense   568 820 1,148 1,639
Common stock issued through employee stock purchase plan       17 26
Common stock issued for vested restricted stock units   0 0 0 1
Common stock issued for Shares, net of offering costs   14,197   21,072  
Offering costs allocated to Pre-Funded Warrants   (453)      
Proceeds allocated for Pre-Funded Warrants, net of offering costs       5,305  
Reclass of warrant liability for March 2026 Private Placement $ 3,900 3,914   3,914  
Ending balance   $ 66,930 44,467 $ 66,930 44,467
Ending balance (in shares)   9,949,609   9,949,609  
Common Stock          
Common Stock Outstanding Roll Forward [Roll Forward]          
Beginning balance   $ 8 $ 5 $ 5 $ 5
Beginning balance (in shares)   7,756,416 4,877,534 5,442,688 4,746,748
Net income (loss)   $ 0 $ 0 $ 0 $ 0
Stock-based compensation expense   0 0 0 0
Common stock issued through employee stock purchase plan       $ 0 $ 0
Common stock issued through employee stock purchase (in shares)       3,600 3,963
Common stock issued for vested restricted stock units   $ 0 $ 0 $ 0 $ 0
Common stock issued for vested restricted stock units (in shares)   19,281 19,333 159,571 146,156
Common stock issued for Shares, net of offering costs   $ 2   $ 5  
Common stock issued for Shares, net of offering costs (in shares)   2,173,912   4,343,750  
Offering costs allocated to Pre-Funded Warrants   $ 0      
Proceeds allocated for Pre-Funded Warrants, net of offering costs       $ 0  
Reclass of warrant liability for March 2026 Private Placement   0   0  
Ending balance   $ 10 $ 5 $ 10 $ 5
Ending balance (in shares)   9,949,609 4,896,867 9,949,609 4,896,867
Additional Paid-in Capital          
Common Stock Outstanding Roll Forward [Roll Forward]          
Beginning balance   $ 447,742 $ 432,453 $ 434,515 $ 431,607
Net income (loss)   0 0 0 0
Stock-based compensation expense   568 820 1,148 1,639
Common stock issued through employee stock purchase plan       17 26
Common stock issued for vested restricted stock units   0 0 0 1
Common stock issued for Shares, net of offering costs   14,195   21,067  
Offering costs allocated to Pre-Funded Warrants   (453)      
Proceeds allocated for Pre-Funded Warrants, net of offering costs       5,305  
Reclass of warrant liability for March 2026 Private Placement   3,914   3,914  
Ending balance   465,966 433,273 465,966 433,273
Accumulated Deficit          
Common Stock Outstanding Roll Forward [Roll Forward]          
Beginning balance   (406,443) (381,926) (385,144) (376,535)
Net income (loss)   7,397 (6,885) (13,902) (12,276)
Stock-based compensation expense   0 0 0 0
Common stock issued through employee stock purchase plan       0 0
Common stock issued for vested restricted stock units   0 0 0 0
Common stock issued for Shares, net of offering costs   0   0  
Offering costs allocated to Pre-Funded Warrants   0      
Proceeds allocated for Pre-Funded Warrants, net of offering costs       0  
Reclass of warrant liability for March 2026 Private Placement   0      
Ending balance   $ (399,046) $ (388,811) $ (399,046) $ (388,811)